SEARCH

Reuters Health News Summary

16 Sep 2020 / 04:58 H.

    Following is a summary of current health news briefs.

    U.S. CDC reports 194,092 deaths from coronavirus

    The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday reported 6,537,627 cases of the new coronavirus, an increase of 34,597 cases from its previous count, and said the number of deaths had risen by 387 to 194,092. The CDC's tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, is as of 4 p.m. ET on Sept. 14 compared with its previous report a day earlier.(https://bit.ly/2GDSzxr)

    UK's creaking COVID-19 test system puts health services at risk

    Britain's testing system for COVID-19 was creaking on Tuesday as a bottleneck prevented people including medics from getting a test, with the government saying it may take weeks to resolve the problem. In an attempt to slow one of the highest coronavirus death tolls in the West, Prime Minister Boris Johnson promised in May to create a "world beating" system to test and trace people exposed to the virus.

    China coronavirus vaccine may be ready for public in November: official

    Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said. China has four COVID-19 vaccines in the final stage of clinical trials. At least three of those have already been offered to essential workers under an emergency use programme launched in July.

    AstraZeneca resumes COVID-19 vaccine trials in South Africa, health department says

    AstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country's Department of Health told Reuters on Tuesday. The move, confirmed to Reuters by director of affordable medicines in the health department, Khadija Jamaloodien, comes after the British drugmaker on Saturday got the go-ahead to restart trials in the UK, prompting Brazil to follow suit.

    Pfizer says late-stage coronavirus vaccine study shows moderate side effects

    Pfizer Inc said on Tuesday participants were showing mild-to-moderate side effects when given either the company's experimental coronavirus vaccine or a placebo in an ongoing late-stage study. Over 12,000 study participants had received a second dose of the vaccine, Pfizer executives said on an investor conference call.

    U.S. FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiry

    The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc's U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do "very significant work" with the company as it conducts its investigation after an illness in a participant in Britain. "We're here to protect the American public and we're going to do very significant work with the company to figure out if there's a significant safety issue or not," FDA Commissioner Stephen Hahn said during an Instagram Live interview with Republican U.S. Senator Tim Scott of South Carolina.

    U.S. COVID-19 death analysis shows greater toll on Black, Hispanic youth: CDC

    A disproportionate percentage of U.S. COVID-19 deaths have been recorded among Black and Hispanic people younger than 21, according to a U.S. study, a reflection of the racial and ethnic make-up of essential workers who have more exposure to COVID-19. The U.S. Centers for Disease Control and Prevention (CDC) reported that from Feb. 12 through July 31, there were 121 deaths among people younger than the age of 21 in 27 states.

    Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare, investigator says

    Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday. The investigator, Alberto Borobia, said there were enough reserve volunteers for the trial to continue as normal, however.

    Apple rolls out virtual fitness service, subscription bundle, catering to pandemic work-from-home

    Apple Inc rolled out a new virtual fitness service and a bundle of all its subscriptions, Apple One, focusing a holiday-season product launch on services that are the backbone of Apple's growth strategy and that cater to customers working at home during the COVID-19 pandemic. Apple also introduced a new Apple Watch Series 6 that monitors blood oxygen and will cost $399, and a lower-cost Apple Watch SE for $279.

    Canada not ruling out lockdown amid COVID-19 surge but eyes 'surgical approach'

    Canada's health minister on Tuesday said she could not rule out another full lockdown if needed amid a surge in new COVID-19 cases, but added Ottawa was significantly more prepared to manage the virus than during the first wave. Patty Hajdu's comments followed a pledge she made late Monday to take a "surgical approach" to tackling outbreaks. Canada reported 1,351 new cases on Sept. 14, the highest single daily addition since May 1, amid school reopenings and flare-ups tied to group gatherings.

    email blast